Summary
Some novel observations dealing with antagonist binding to cardiac particulate muscarinic receptors are described. Gpp(NH)p increased (2–3 fold) the specific binding of [3H]-QNB or [3H]-NMS, both potent muscarinic antagonists, to washed particles (WP), but not microsomes (MIC), when the binding was conducted at 30°C. Magnesium, on the other hand, increased (2–3 fold) the binding of these antagonists to MIC, but not to WP, under the same condition. The treatment of subcellular fractions with 0.2 mM N-ethylmaleimide (NEM), a sulfhydryl reagent, failed to significantly modify the respective stimulatory actions of either Gpp(NH)p on WP binding or of magnesium on MIC binding of these antagonists; treatment with dithiothreitol (1 mM) was also ineffective in this regard. Gpp(NH)p decreased Kd (WP) while magnesium increased Kd (MIC) for [3H]-QNB. Repeated freezing/thawing of isolated subcellular fractions abolished the stimulatory effect of magnesium on onist binding to MIC but not of Gpp(NH)p on WP antagonist binding; the freeze/thaw procedure per se increased MIC binding but not WP binding of these antagonists. When the binding was conducted at 4°C (24 hr), the stimulatory effect of Gpp(NH)p on [3H]-QNB binding was enhanced (6-fold) in the case of WP and was detectable (80%) in the case of MIC. Under this condition, the stimulatory effect of magnesium on [3H]-QNB binding was also enhanced (5-fold) in the case of MIC and became evident (200%) in the case of WP. The results of this work support the following views: (a) antagonist-occupied cardiac muscarinic receptors are capable of interaction with guanine nucleotide binding proteins (G protein like G1,Go) and such interaction influences antagonist binding properties (e.g. increased affinity) of the cardiac membrane-associated muscarinic receptors (b) magnesium influences (decreased affinity) antagonist binding properties by interacting with multiple sites of which some are likely associated with components other than G proteins of the particulate fractions (c) a pool of NEM-sensitive sulfhydryls involved in the regulation of Gpp(NH)p-sensitive agonist binding to cardiac muscarinic receptors is not involved in the regulation by either Gpp(NH)p or magnesium of antagonist binding in these subcellular fractions and (d) membrane fluidity and microenvironment surrounding the receptor and G proteins contribute to the actions of Gpp(NH)p and magnesium on antagonist binding.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fukuda JT, Kubo T, Akiba I, Maeda A, Mishina M, Numa S: Molecular distinction between muscarinic acetylcholine receptor subtype. Nature 327: 623–625, 1987
Peralta EG, Winslow JW, Peterson GL, Smith DH, Ashkenazi A, Ramachandran J, Schimerlik MI, Capon DJ: Primary structure and biochemical properties of an M2 muscarinic receptor. Science 236: 600–605, 1987
Birdsall NMJ, Hulme EC: Muscarinic receptor subclasses. Trends Pharmacol 4: 459–463, 1983
Vickroy TW, Watson M, Yamamura HI, Roeske WR: Agonist binding to multiple muscarinic receptors. Fed Proc 43: 2785–2790, 1984
Braun AP, Sulakhe PV: Muscarinic cholinergic receptors. In: AA Bolton, GB Baker, PD Hrdina (eds) Neuromethods. 4 Receptor Binding. Humana Press, Clifton, New Jersey, 1986, pp 139–170
Uchida S, Matsumoto K, Mizushima A, Osugi T, Higuchi H, Yoshida H: Effects of guanine nucleotide and sulfhydryl reagent on subpopulations of muscarinic acetylcholine receptors in mammalian hearts: Possible evidence for interconversion of super-high and low affinity agonist binding sites. Eur J Pharmacol 100: 291–298, 1984
McMahon KK, Hosey MM: Agonist interaction with cardiac muscarinic receptors: Effects of Mg, guanine nucleotides and monovalent cations. Mol Pharmacol 28: 400–409, 1985
Berrie CP, Birdsall NMJ, Burgen ASV, Hulme EC: Guanine nucleotides modulate muscarinic receptor binding in the heart. Biochem Biophys Res Commun 27: 1000–1005, 1979
Rosenberger LB, Roeske WR, Yamamura HI: The regulation of muscarinic cholinergic receptors by guanine nucleotides in cardiac tissue. Eur J Pharmacol 56: 179–180, 1979
Wei JW, Sulakhe PV: Agonist-antagonist interactions with rat atrial muscarinic cholinergic receptor sites: Differential regulation by guanine nucleotides. Eur J Pharmacol 58: 91–92, 1979
Burgisser E, De Lean A, Lefkowitz RJ: Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide. Proc Natl Acad Sci USA 79: 1732–1736, 1982
Martin MW, Smith MM, Harden TK: Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart. J Pharmacol Expt Ther 230: 424–430, 1984
Florio VA, Sternweis PC: Mechanisms of muscarinic receptor action on Go in reconstituted phospholipid vesicles. J Biol Chem 264: 3909–3915, 1989
Haga K, Uchiyama H, Haga T, Ichiyama A, Kanagawa K, Matsuo H: Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components. Mol Pharmacol 35: 286–294, 1989
Wei JW, Sulakhe PV: Requirement for sulfhydryl groups in the differential effects of magnesium ion and GTP on agonist binding of muscarinic cholinergic receptor sites in rat atrial membrane fraction. NS Arch Pharmacol 314: 51–59, 1980
Harden TK, Scheer AG, Smith MM: Differential modification of the interaction of cardiac muscarinic cholinergic and beta-adrenergic receptors with a guanine nucleotide binding component(s). Mol Pharmacol 21: 570–580, 1982
Harden TK, Meeker RB, Smith MM: Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors. J Pharmacol Exp Ther 227: 570–577, 1983
Flynn DD, Potter LT: Different effects of N-ethylmaleimide on M1 and M2 muscarinic receptors in rat brain. Proc Natl Acad Sci USA 82: 580–583, 1985
Wei JW, Sulakhe PV: Cardiac muscarinic cholinergic receptor sites: Opposing regulation by divalent cations and guanine nucleotides of receptor-agonist interaction. Eur J Pharmacol 62: 345–347, 1980
Hulme EC, Berrie CP, Birdsall NMJ, Jameson M, Stockton JM: Regulation of muscarinic agonist binding by cations and guanine nucleotides. Eur J Pharmacol 94: 59–72, 1983
Hulme EC, Berrie CP, Birdsall NMJ, Burgen ASV: Two populations of binding sites for muscarinic antagonists in the rat heart. Eur J Pharmacol 73: 137–142, 1981
Hosey MM: Regulation of antagonist binding to cardiac muscarinic receptors. Biochem Biophys Res Commun 107: 314–321, 1982
Ehlert F, Roeske WR, Yamamura HI: Muscarinic cholinergic receptor heterogeneity. Trends Neurosci 5: 336–339, 1981
Wei JW, Sulakhe PV: Properties of the muscarinic cholinergic receptors in rat atrium. NS Arch Pharmacol 309: 259–269, 1979
Wei JW, Sulakhe PV: Lowering temperature increases cardiac muscarinic receptor site affinity towards agonists and antagonists. Gen Pharmacol 13: 413–419, 1982
Muzio F, Malandrino S, Ferrari M, Tonon G: Temperature effect on subclasses of muscarinic receptors in rat colon, heart and cerebral cortex. Life Sci 39: 365–371, 1986
De Lean A, Stadel JM, Lefkowitz RJ: A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta adrenergic receptor. J Biol Chem 255: 7108–7117, 1980
Casey PJ, Gilman AG: G protein involvement in receptoreffector coupling. J Biol Chem 263: 2577–2580, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sulakhe, P.V., Jagadeesh, G., Phan, N.T. et al. MgCl2-sensitive and Gpp(NH)p-sensitive antagonist binding states of rat heart muscarinic receptors: preferential detection at ambient temperature assay and location in two subcellular fractions. Mol Cell Biochem 94, 133–146 (1990). https://doi.org/10.1007/BF00214120
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00214120